Tonix Pharmaceuticals Holding Corp.
TNXP
$13.35
$0.110.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.63% | 26.64% | 45.36% | -33.81% | -11.47% |
| Total Depreciation and Amortization | -43.73% | -56.31% | -43.49% | -34.12% | -20.27% |
| Total Amortization of Deferred Charges | -92.26% | -34.08% | -102.79% | -19.72% | -- |
| Total Other Non-Cash Items | -80.02% | -82.23% | -83.72% | 2,839.01% | 468.08% |
| Change in Net Operating Assets | 79.77% | 4,116.55% | -49.92% | -71.88% | 16,600.00% |
| Cash from Operations | -63.88% | -9.02% | 11.44% | 30.85% | 40.27% |
| Capital Expenditure | -2,707.50% | -169.91% | 76.90% | 99.57% | 98.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3,673.33% | -540.51% | -88.01% | 99.93% | 99.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -310.64% | -529.48% | -1,076.60% | -4,906.38% | -- |
| Issuance of Common Stock | 67.29% | 282.90% | 599.11% | 1,002.40% | 577.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.53% | -166.06% | -154.53% | -162.94% | -151.78% |
| Cash from Financing | 59.06% | 165.99% | 250.52% | 286.19% | 269.34% |
| Foreign Exchange rate Adjustments | -875.00% | 123.33% | 76.00% | 96.15% | 106.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.16% | 664.48% | 682.51% | 293.99% | 178.03% |